EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 3.0

Association Between Alpha-1 Adrenoreceptor Antagonist Use and Cognitive Impairment: A Systematic Review

Ryan Kingsley, Sara Tyree, Dhairya Jarsania, Christopher Edquist, Allyson Palmer, Dana Gerberi, Robert Wilfahrt, Sandeep Pagali

International Neurourology Journal · 30.09.2024 · 28 (3) · 171-180

DOI: 10.5213/inj.2448266.133 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Neurourology Journal, erschienen am 30.09.2024. Verfasst von Ryan Kingsley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Medicine, Mayo Clinic, Rochester, MN, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha-1 adrenergic receptor (α1-AR) antagonists are commonly used for management of benign prostatic hyperplasia or hypertension. Some studies have shown a potential link between α1-AR antagonist use and cognitive impairment. Given the conflicting data surrounding α1-AR antagonists association with cognitive dysfunction, we aim to systematically review the association of cognitive dysfunction with α1-AR antagonist use to aid clinician decision both with medication initiation and continuation. A systematic review was performed following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We searched Ovid Cochrane, Ovid Embase, Ovid MEDLINE, Scopus, and Web of Science on March 7, 2023, with an update run on January 22, 2024. The primary outcome was cognitive dysfunction. We used Cochrane risk of bias for randomized controlled trials (RCTs) and MINORS (Methodological Index for Non-Randomized Studies) criteria for non-RCTs to evaluate study quality. This study was registered with PROSPERO (CRD42024505751). We identified 7 studies for our systematic review (3 RCTs, 4 non-RCTs). Tamsulosin was the most studied medication (6 of 7 studies). Tamsulosin was associated with no cognitive dysfunction in 2 RCTs, increased risk for dementia in 2 non-RCTs, no change in cognition in 1 non-RCT, and decreased risk for dementia in 1 non-RCT. Among 3 non-RCTs analyzing alfuzosin, it was associated with decreased risk of or no association with dementia in 2 studies and increased risk for dementia in 1 study. Doxazosin, prazosin, and terazosin were neutral or showed a negative risk for dementia. Our systematic review did not show a convincing causal association between α1-AR antagonists, including tamsulosin, and cognitive dysfunction. Considering the existing literature, it is appropriate to use α1-AR antagonists without concern for cognitive dysfunction. Future research, through robust study designs considering the multifactorial nature of cognitive dysfunction, is required to further evaluate this association.

Schlagwörter

Stichwörter der Autor:innen

Alpha blockerAlzheimer diseaseCognitive impairmentDementiaSystematic review

Autor:innen und Institutionen

  • Division of Hospital Medicine, Mayo Clinic, Rochester, MN, USA.
  • Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
  • Department of Library Services, Mayo Clinic, Rochester, MN, USA.
  • Division of Family Medicine, Mayo Clinic, Rochester, MN, USA.

Zitieren

APA

Kingsley, R., Tyree, S., Jarsania, D., Edquist, C., Palmer, A., Gerberi, D., Wilfahrt, R., & Pagali, S. (2024). Association Between Alpha-1 Adrenoreceptor Antagonist Use and Cognitive Impairment: A Systematic Review. International Neurourology Journal, 28(3), 171-180. https://doi.org/10.5213/inj.2448266.133

Vancouver

Kingsley R, Tyree S, Jarsania D, Edquist C, Palmer A, Gerberi D, et al. Association Between Alpha-1 Adrenoreceptor Antagonist Use and Cognitive Impairment: A Systematic Review. International Neurourology Journal. 2024;28(3):171-180. doi:10.5213/inj.2448266.133

BibTeX
@article{Kingsley2024,
  author = {Kingsley, Ryan and Tyree, Sara and Jarsania, Dhairya and Edquist, Christopher and Palmer, Allyson and Gerberi, Dana and Wilfahrt, Robert and Pagali, Sandeep},
  title = {Association Between Alpha-1 Adrenoreceptor Antagonist Use and Cognitive Impairment: A Systematic Review},
  journal = {International Neurourology Journal},
  year = {2024},
  volume = {28},
  number = {3},
  pages = {171--180},
  doi = {10.5213/inj.2448266.133}
}
Kostenlos starten →